Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Ensuring raw materials are virus-free is still a major challenge for the cell an...
These “on‑demand” probes, known as VIS‑Fbs (visible-spectrum target-stabilizable...
Data from Cosmo’s Phase III program for clascoterone confirmed the drug’s long-t...
Path-IO accurately stratified immunotherapy outcomes for patients with metastati...
The brain’s resident immune cells, microglia, amass mutations in specific cancer...
In this eBook, Marken experts share how these precision-driven services ensure t...
From the AACR Annual Meeting in San Diego, Julianna LeMieux and Damian Doherty r...
Using genome‑wide CRISPR activation and knockout screens in primary human T cell...
Freudenberg Medical manufactures silicone and thermoplastic elastomer tubing for...
Kelonia’s lead program KLN-1010 is a one-time intravenous gene therapy designed ...
Using engineered liver tissue as a proof-of-concept application, researchers int...
By analyzing CpG-based DNA methylation, researchers from Kindai University in Ja...
If you want to capture something wolflike, it’s best to embark before dawn. So o...
Developing resistant models directly from patient tumors can take years due to s...
As biotech celebrates its 50th year, we are locked in “the fight of our lives” t...
In the trial’s overall (intent-to-treat) study population, daraxonrasib showed a...